Hereditary Angioedema - 12 Studies Found
| COMPLETED |
: Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II : Hereditary Angioedema : 2025-08-31 : Deucrictibant softgel capsules for oral use (PHVS416) |
| COMPLETED |
: A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr�) in Persons With HAE in China : Hereditary Angioedema (HAE) : 2025-08-31 : This is a non-interventional study. |